118 related articles for article (PubMed ID: 22594928)
1. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Suwanchatchai W; Tanglertsampan C; Pengsalae N; Makornwattana M
J Dermatol; 2012 Oct; 39(10):865-6. PubMed ID: 22594928
[No Abstract] [Full Text] [Related]
2. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study.
Lee S; Tanglertsampan C; Tanchotikul M; Worapunpong N
J Dermatol; 2014 Feb; 41(2):149-52. PubMed ID: 24471459
[TBL] [Abstract][Full Text] [Related]
3. Topical bimatoprost for the treatment of eyebrow hypotrichosis.
Schweiger ES; Pinchover L; Bernstein RM
J Drugs Dermatol; 2012 Jan; 11(1):106-8. PubMed ID: 22206085
[TBL] [Abstract][Full Text] [Related]
4. Treatment of eyebrow hypotrichosis using bimatoprost: a randomized, double-blind, vehicle-controlled pilot study.
Beer KR; Julius H; Dunn M; Wilson F
Dermatol Surg; 2013 Jul; 39(7):1079-87. PubMed ID: 23617229
[TBL] [Abstract][Full Text] [Related]
5. Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension.
Katz LJ; Cohen JS; Batoosingh AL; Felix C; Shu V; Schiffman RM
Am J Ophthalmol; 2010 Apr; 149(4):661-671.e1. PubMed ID: 20346780
[TBL] [Abstract][Full Text] [Related]
6. Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancement.
Woodward JA; Haggerty CJ; Stinnett SS; Williams ZY
J Cosmet Dermatol; 2010 Jun; 9(2):96-102. PubMed ID: 20618554
[TBL] [Abstract][Full Text] [Related]
7. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.
Smith S; Fagien S; Whitcup SM; Ledon F; Somogyi C; Weng E; Beddingfield FC
J Am Acad Dermatol; 2012 May; 66(5):801-6. PubMed ID: 21899919
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial.
Zaky MS; Hashem OA; Mahfouz SM; Elsaie ML
Arch Dermatol Res; 2023 Nov; 315(9):2635-2641. PubMed ID: 37517060
[TBL] [Abstract][Full Text] [Related]
10. Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.
Brandt JD; Cantor LB; Katz LJ; Batoosingh AL; Chou C; Bossowska I;
J Glaucoma; 2008; 17(3):211-6. PubMed ID: 18414107
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
Tanglertsampan C
J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
[TBL] [Abstract][Full Text] [Related]
12. Bimatoprost 0.03% solution (latisse) for eyelash enhancement.
Med Lett Drugs Ther; 2009 Jun; 51(1313):43-4. PubMed ID: 19478690
[No Abstract] [Full Text] [Related]
13. Bimatoprost ophthalmic solution 0.03% for eyebrow growth.
Elias MJ; Weiss J; Weiss E
Dermatol Surg; 2011 Jul; 37(7):1057-9. PubMed ID: 21457389
[No Abstract] [Full Text] [Related]
14. Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.
Aydin S; Işikligil I; Tekşen YA; Kir E
Cutan Ocul Toxicol; 2010 Sep; 29(3):212-6. PubMed ID: 20670089
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.
Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma.
Konstas AG; Holló G; Mikropoulos D; Tsironi S; Haidich AB; Embeslidis T; Georgiadou I; Irkec M; Melamed S
Br J Ophthalmol; 2010 Feb; 94(2):209-13. PubMed ID: 19825835
[TBL] [Abstract][Full Text] [Related]
17. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy and safety of using 0.01% versus 0.03% bimatoprost for the treatment of eyebrow hypotrichosis: A randomized, double-blind, split-face, comparative study.
Suchonwanit P; Harnchoowong S; Chanasumon N; Sriphojanart T
J Cosmet Dermatol; 2020 Mar; 19(3):714-719. PubMed ID: 31317662
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ocular surface side effects of topical travoprost and bimatoprost.
Alagöz G; Bayer A; Boran C; Serin D; Kükner A; Elçioğlu M
Ophthalmologica; 2008; 222(3):161-7. PubMed ID: 18497524
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
